A detailed history of Wealthcare Advisory Partners LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Wealthcare Advisory Partners LLC holds 8,635 shares of GH stock, worth $197,568. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,635
Holding current value
$197,568
% of portfolio
0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$16.07 - $31.84 $138,764 - $274,938
8,635 New
8,635 $249,000
Q4 2023

Feb 06, 2024

BUY
$21.58 - $29.5 $28,226 - $38,586
1,308 Added 17.95%
8,596 $232,000
Q3 2023

Oct 12, 2023

SELL
$25.8 - $39.97 $258 - $399
-10 Reduced 0.14%
7,288 $216,000
Q2 2023

Jul 17, 2023

BUY
$20.94 - $38.01 $152,820 - $277,396
7,298 New
7,298 $261,000
Q4 2022

Feb 13, 2023

SELL
$25.44 - $59.78 $4,604 - $10,820
-181 Reduced 2.23%
7,951 $216,000
Q3 2022

Nov 14, 2022

BUY
$43.66 - $61.0 $9,605 - $13,420
220 Added 2.78%
8,132 $438,000
Q2 2022

Aug 15, 2022

BUY
$28.82 - $77.35 $61,328 - $164,600
2,128 Added 36.79%
7,912 $319,000
Q1 2022

Apr 15, 2022

SELL
$48.25 - $100.49 $5,211 - $10,852
-108 Reduced 1.83%
5,784 $383,000
Q4 2021

Feb 11, 2022

BUY
$88.71 - $120.43 $68,661 - $93,212
774 Added 15.12%
5,892 $589,000
Q3 2021

Nov 15, 2021

SELL
$98.77 - $132.17 $6,815 - $9,119
-69 Reduced 1.33%
5,118 $640,000
Q2 2021

Aug 16, 2021

BUY
$109.77 - $165.68 $76,399 - $115,313
696 Added 15.5%
5,187 $644,000
Q1 2021

Apr 30, 2021

BUY
$127.04 - $179.1 $351,138 - $495,032
2,764 Added 160.05%
4,491 $686,000
Q4 2020

Feb 12, 2021

BUY
$99.96 - $135.93 $172,630 - $234,751
1,727 New
1,727 $223,000
Q2 2020

Jul 29, 2020

SELL
$60.49 - $97.5 $34,116 - $54,990
-564 Closed
0 $0
Q1 2020

Apr 29, 2020

BUY
$59.04 - $88.81 $33,298 - $50,088
564 New
564 $39,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $2.34B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Wealthcare Advisory Partners LLC Portfolio

Follow Wealthcare Advisory Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.